Longitudinal DNA methylation dynamics as a practical indicator in clinical epigenetics.

Blood DNA methylation EWAS marker likelihood Illumina 450 K beadchip Temporal stability

Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
13 12 2021
Historique:
received: 13 07 2021
accepted: 24 11 2021
entrez: 14 12 2021
pubmed: 15 12 2021
medline: 1 2 2022
Statut: epublish

Résumé

One of the fundamental assumptions of DNA methylation in clinical epigenetics is that DNA methylation status can change over time with or without interplay with environmental and clinical conditions. However, little is known about how DNA methylation status changes over time under ordinary environmental and clinical conditions. In this study, we revisited the high frequency longitudinal DNA methylation data of two Japanese males (24 time-points within three months) and characterized the longitudinal dynamics. The results showed that the majority of CpGs on Illumina HumanMethylation450 BeadChip probe set were longitudinally stable over the time period of three months. Focusing on dynamic and stable CpGs extracted from datasets, dynamic CpGs were more likely to be reported as epigenome-wide association study (EWAS) markers of various traits, especially those of immune- and inflammatory-related traits; meanwhile, the stable CpGs were enriched in metabolism-related genes and were less likely to be EWAS markers, indicating that the stable CpGs are stable both in the short-term within individuals and under various environmental and clinical conditions. This study indicates that CpGs with different stabilities are involved in different functions and traits, and thus, they are potential indicators that can be applied for clinical epigenetic studies to outline underlying mechanisms.

Sections du résumé

BACKGROUND
One of the fundamental assumptions of DNA methylation in clinical epigenetics is that DNA methylation status can change over time with or without interplay with environmental and clinical conditions. However, little is known about how DNA methylation status changes over time under ordinary environmental and clinical conditions. In this study, we revisited the high frequency longitudinal DNA methylation data of two Japanese males (24 time-points within three months) and characterized the longitudinal dynamics.
RESULTS
The results showed that the majority of CpGs on Illumina HumanMethylation450 BeadChip probe set were longitudinally stable over the time period of three months. Focusing on dynamic and stable CpGs extracted from datasets, dynamic CpGs were more likely to be reported as epigenome-wide association study (EWAS) markers of various traits, especially those of immune- and inflammatory-related traits; meanwhile, the stable CpGs were enriched in metabolism-related genes and were less likely to be EWAS markers, indicating that the stable CpGs are stable both in the short-term within individuals and under various environmental and clinical conditions.
CONCLUSIONS
This study indicates that CpGs with different stabilities are involved in different functions and traits, and thus, they are potential indicators that can be applied for clinical epigenetic studies to outline underlying mechanisms.

Identifiants

pubmed: 34903243
doi: 10.1186/s13148-021-01202-6
pii: 10.1186/s13148-021-01202-6
pmc: PMC8670275
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

219

Informations de copyright

© 2021. The Author(s).

Références

Z Rheumatol. 2018 Nov;77(9):789-798
pubmed: 30291433
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Reprod Toxicol. 2017 Mar;68:3-33
pubmed: 27760374
Medicina (Kaunas). 2019 Sep 24;55(10):
pubmed: 31554310
Aging Cell. 2019 Dec;18(6):e13028
pubmed: 31496122
Sci Total Environ. 2019 Feb 10;650(Pt 1):908-921
pubmed: 30308865
Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225
pubmed: 28639538
Sci Rep. 2017 Dec 8;7(1):17275
pubmed: 29222500
Sci Rep. 2017 Aug 25;7(1):9452
pubmed: 28842709
Eur J Appl Physiol. 2016 Jun;116(6):1245-53
pubmed: 27155847
Dialogues Clin Neurosci. 2018 Mar;20(1):63-73
pubmed: 29946213
Am J Respir Crit Care Med. 2007 Aug 15;176(4):370-6
pubmed: 17463411
Nat Rev Genet. 2008 Nov;9(11):819-30
pubmed: 18852695
Brief Bioinform. 2014 Nov;15(6):929-41
pubmed: 23990268
JAMA. 2019 Aug 13;322(6):546-556
pubmed: 31408135
Cell. 1996 Aug 9;86(3):353-64
pubmed: 8756718
Diabetes Care. 2012 May;35(5):1171-80
pubmed: 22517938
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
PLoS One. 2012;7(12):e51155
pubmed: 23251443
Hum Reprod. 2015 May;30(5):1014-28
pubmed: 25753583
Nucleic Acids Res. 2021 Jan 8;49(D1):D536-D544
pubmed: 33179747
Epigenetics. 2018;13(10-11):1056-1071
pubmed: 30270718
Bioinformatics. 2017 Aug 1;33(15):2381-2383
pubmed: 28369316
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):221-9
pubmed: 25371448
J Appl Physiol (1985). 2015 Feb 15;118(4):475-88
pubmed: 25539938
NPJ Genom Med. 2017 Apr 13;2:11
pubmed: 29263827
J Psychiatry Neurosci. 2006 Nov;31(6):414
pubmed: 17136222
FASEB J. 2010 Sep;24(9):3135-44
pubmed: 20385621
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
Lancet. 2018 Sep 1;392(10149):777-786
pubmed: 30100054
Am J Med Genet B Neuropsychiatr Genet. 2020 Sep;183(6):309-330
pubmed: 32681593
Genes (Basel). 2019 May 19;10(5):
pubmed: 31109152
Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):490-7
pubmed: 25538225
Nat Rev Genet. 2019 Feb;20(2):109-127
pubmed: 30479381
Hum Genome Var. 2018 Mar 29;5:18008
pubmed: 29619235
Diabetes Care. 2004 Dec;27(12):2856-62
pubmed: 15562197
Reprod Biomed Online. 2016 Dec;33(6):709-719
pubmed: 27692602
Hum Reprod. 2018 Dec 1;33(12):2256-2267
pubmed: 30358834
Bioinformatics. 2016 Jan 15;32(2):286-8
pubmed: 26424855
Eur J Hum Genet. 2017 Dec;25(12):1335-1344
pubmed: 29255178
Environ Int. 2018 Nov;120:11-21
pubmed: 30055357
J Neurochem. 2015 Aug;134(4):783-93
pubmed: 25977097
J Appl Physiol (1985). 2005 Apr;98(4):1154-62
pubmed: 15772055
PLoS One. 2012;7(6):e39220
pubmed: 22745719
Epigenetics. 2018;13(9):959-974
pubmed: 30239288
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Transl Psychiatry. 2017 Jan 24;7(1):e1007
pubmed: 28117839
Nucleic Acids Res. 2019 Jan 8;47(D1):D983-D988
pubmed: 30364969
BMC Genomics. 2013 May 01;14:293
pubmed: 23631413
Sci Rep. 2016 May 19;6:26424
pubmed: 27192970
Epigenetics. 2014 Dec;9(12):1557-69
pubmed: 25484259
Int J Chron Obstruct Pulmon Dis. 2009;4:233-43
pubmed: 19554194
Nat Med. 2003 Jun;9(6):653-60
pubmed: 12778163

Auteurs

Shohei Komaki (S)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Hideki Ohmomo (H)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Tsuyoshi Hachiya (T)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Yoichi Sutoh (Y)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Kanako Ono (K)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Ryohei Furukawa (R)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.
Department of Biology, Research and Education Center for Natural Sciences, Keio University, 4-1-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa, 223-8521, Japan.

So Umekage (S)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Yayoi Otsuka-Yamasaki (Y)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan.

Kozo Tanno (K)

Division of Clinical Research and Epidemiology, Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.
Department of Hygiene and Preventive Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Shiwa, Iwate, 028-3694, Japan.

Makoto Sasaki (M)

Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.
Division of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Shiwa, Iwate, 028-3694, Japan.

Atsushi Shimizu (A)

Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, 028-3694, Japan. ashimizu@iwate-med.ac.jp.
Division of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Shiwa, Iwate, 028-3694, Japan. ashimizu@iwate-med.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH